FindTrial
Sign In

The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy

The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01876576
Enrollment
175
Registered
2013-06-12
Start date
2012-04-30
Completion date
2013-04-30
Last updated
2013-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Diseases

Keywords

colonoscopy

Brief summary

This study will evaluate the expansion of dietary options from clear liquids the entire day to a low reside breakfast and lunch for patients prior to undergoing bowel preparation with MoviPrep® and its effect on preparation quality for colonoscopy.

Detailed description

This study will evaluate the expansion of dietary options from clear liquids the entire day to a low reside breakfast and lunch for patients prior to undergoing bowel preparation with MoviPrep® and its effect on preparation quality for colonoscopy. MoviPrep® is a commercially available 2 liter bowel purgative for use before colonoscopy in adults 18 years of age or older that is comprised of polyethylene glycol-electrolyte solution (PEG-ELS) plus sodium sulfate, sodium ascorbate, and ascorbic acid.

Interventions

OTHERClear liquids

Clear liquids

OTHERLow residue breakfast and lunch

Low residue

Sponsors

Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective outpatients \> 18 yrs undergoing colonoscopy

Exclusion criteria

* Unable or unwilling to give informed consent * Age \< 18 years * Pregnant * Breast feeding * Gastroparesis - established or suspected * Pseudo-obstruction - established or suspected * Severe constipation (\< 1 BM a week) * Bowel obstruction * Colon resection * Chronic nausea or vomiting * Known Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency * PEG allergy * Significant psychiatric illness

Design outcomes

Primary

MeasureTime frame
Efficacy - Overall bowel cleansing based on Boston Bowel Preparation Scale score BBPS score of 2-3 for each segment AND total score1 day (At colonoscopy)

Secondary

MeasureTime frame
Efficacy - Individual colon segment cleansing Successful cleansing defined as BBPS score of 2 - 3 for a segment1 day (At colonoscopy)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026